Livermore, CA, United States of America

Jeanne Harvey

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeanne Harvey

Introduction

Jeanne Harvey is a prominent inventor based in Livermore, California, known for her significant contributions to the field of cancer diagnostics and treatment. With a total of 10 patents to her name, she has developed groundbreaking technologies that enhance the understanding and treatment of cancer.

Latest Patents

Among her latest patents is the invention of antibody-based arrays for detecting multiple signal transducers in rare circulating cells. This invention provides a method for detecting the activation state and total amount of various signal transduction molecules in rare circulating cells, facilitating cancer prognosis and diagnosis, as well as the design of personalized, targeted therapies. Another notable patent involves methods for detecting truncated receptors using antibody-based arrays. This invention offers compositions and methods for assessing the activation states of components of signal transduction pathways in tumor cells, which can be crucial for cancer diagnosis, prognosis, and treatment design.

Career Highlights

Throughout her career, Jeanne has worked with notable companies such as Nestec S.A. and Prometheus Laboratories Inc. Her work has significantly impacted the field of cancer research and treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Jeanne has collaborated with esteemed colleagues, including Sharat Singh and Phillip Kim, further enhancing her innovative work in the field.

Conclusion

Jeanne Harvey's contributions to cancer diagnostics and treatment through her innovative patents and collaborations highlight her as a leading figure in the field. Her work continues to pave the way for advancements in personalized medicine and cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…